Windtree Therapeutics Q2 2024 GAAP EPS $(20.91) Misses $(2.27) Estimate
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.